Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating scientific insight into breakthrough medicines. Our deep understanding of the role of Tissue Factor in angiogenesis, inflammation and malignancies has led us to a new approach to developing therapies for devastating diseases such as macular degeneration and cancer. Our highly experienced management team is brought together by a shared commitment to working with passion, changing medicine and building an outstanding company. We partner with world-renowned researchers, preeminent clinicians and key advocacy groups to advance our programs. Iconic is backed by top tier life science investors and is guided by an outstanding Board of Directors comprised of biotechnology industry leaders.